Robert F Kennedy's decision to cut 500 million US dollars in research funding impacts mRNA vaccine development. This decision ...

HHS reinstates vaccine safety task force apparently in response to looming lawsuit deadline by group Secretary Kennedy ...

One of the more notable successes of President Donald Trump’s first term was how the administration was able to develop ...

For a small group of people scattered across the world, living with a rare immune condition comes with an unexpected twist: ...

AstraZeneca’s FluMist, the only nasal spray flu vaccine in the US that has been approved by the US Food and Drug ...

Key Takeaways The S&P 500 slipped 0.3% on Friday, Aug. 15, 2025, as a report on consumer sentiment revealed growing concerns about tariff impacts, inflation, and the jobs market.UnitedHealth stock ...

The Nobel Prize-winning technology underpinning COVID-19 vaccines is also fueling a host of biotechs developing treatments ...

The rest of the world is not following the US government’s dangerous path, and will stick with the technology that helped the ...

In the days after a deadly shooting, CDC employees said they feel frustrated with federal leaders due to a lack of statements and for the peddling of vaccine skepticism.

If another pandemic happens, abandoning mRNA research now risks destroying a signature Trump achievement, leaving America ...

The average short interest in the S&P 500 Health Care Index Sector (XLV) dipped slightly in July to 1.95% from 1.96% in June.

The Department of Health and Human Services’ mRNA pullback only applies to their use in upper respiratory disease, according ...